|
|
||||||||
RESEARCH REPORT |
Oral Biology and Pathology, School of Dentistry, The University of Queensland, Brisbane 4072, Australia;
* corresponding author, e.gemmell{at}uq.edu.au
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: mast cells periodontal disease immunohistology
| INTRODUCTION |
|---|
|
|
|---|
While the primary role for mast cells was thought to be in the innate defense against intestinal and cutaneous parasitic and bacterial infections, they are now believed also to play a role in the induction of acquired immune responses (Mécheri and David, 1997). Mast cells have been reported to reside close to T-cells (Mekori and Metcalf, 1999), can phagocytose and process bacterial antigens prior to presentation of antigens to T-cells (Malaviya et al., 1996), and are a source of Th1- and Th2-inducing cytokines (Plaut et al., 1989; Smith et al., 1994; Marietta et al., 1996).
The aim of the present study was to determine the relationship between mast cells and the Th1/Th2 response in human periodontal disease. Tryptase+ and c-kit+ mast cells were first demonstrated in biopsies from healthy/gingivitis and chronic periodontitis patients. Stem cell factor is a differentiation and proliferation factor for mast cells and is a ligand for the receptor that is encoded by the c-kit proto-oncogene (Galli et al., 1995). Second, mast cells produce IL-4, IL-10, and IL-13 (Plaut et al., 1989; Marietta et al., 1996), which direct Th2 responses, and IL-12 (Smith et al., 1994), which induces IFN-gamma production (Chan et al., 1991), contributing to the development of a Th1 response. Since interferon gamma and IL-4 induce T-cell-dependent isotype switching in B-cells to IgG2 and IgG4, respectively (Agresti and Vercelli, 2002; Tanaka et al., 2003), IgG2+ and IgG4+ B-cells/plasma cell numbers were also examined.
| MATERIALS & METHODS |
|---|
|
|
|---|
Preparation of Tissue
Tissue samples were prepared, and cryostat sections were cut and fixed as described by Gemmell and Seymour (1995).
Immunoperoxidase Technique
Mast cells were labeled according to an avidin-biotin immunoperoxidase method described previously (Gemmell and Seymour, 1995). The antibodies used were mouse anti-human tryptase (1/20) and rabbit anti-human c-kit (1/20), followed by biotinylated rabbit anti-mouse and swine anti-rabbit immunoglobulins, respectively (1/50), and finally streptavidin peroxidase (1/50) (DAKO, Glostrup, Denmark). IgG2+ and IgG4+ B-cells/plasma cells were stained by a direct immunoperoxidase method described previously (Gemmell et al., 2003), with horseradish peroxidase conjugated mouse anti-human IgG2 and IgG4 antibodies (Zymed Laboratories Inc., South San Francisco, CA, USA).
Cell Analysis
Using hematoxylin-and-eosin-stained sections, we evaluated each healthy/gingivitis or chronic periodontitis tissue sample with respect to the size of the connective tissue inflammatory infiltrate as described by Seymour et al.(1983). As described previously (Reinhardt et al., 1988; Gemmell and Seymour, 1995), biopsies with small infiltrates confined to the upper 1/3 of the section in the region adjacent to the junctional and sulcular epithelium were placed in a group defined as "small". The "medium" group contained sections with infiltrates which occupied the upper 2/3 of the section, and infiltrates extended throughout the entire section in the "large" group.
Using a graticule, we counted the numbers of tryptase+ and c-kit+ mast cells and IgG2+ and IgG4+ cells in 10 representative high-power fields (X400) and determined the mean (± standard error of the mean) numbers/2.5 mm2 in the healthy/gingivitis and chronic periodontitis tissues, as well as those in the three groups within each of these two main categories.
Statistical Analysis
We used multivariate analysis of variance with the general linear model to test for differences between the numbers of tryptase+ and c-kit+ mast cells as well as numbers of IgG2+ and IgG4+ cells. Selected pairs of groups were then tested for significance by the Student t test. We used the Minitab statistical package (Minitab Inc., State College, PA, USA) to perform the analyses.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Mast cells reside close to T-cells (Mekori and Metcalfe, 1999), phagocytose and process antigens, and initiate acquired immune responses by presenting antigens to T-cells (Fox et al., 1994; Frandji et al., 1996; Malaviya et al., 1996). Since T-lymphocytes have been shown to predominate in the stable periodontal lesion with an increase in the numbers of B-cells and plasma cells in the progressive lesion, there has been the suggestion that T-cells with a Th1 cytokine profile may be the major mediator in periodontitis, while Th2 cells play a role in periodontitis (reviewed in Gemmell et al., 2002). Interferon gamma and IL-4 induce T-cell-dependent isotype switching in B-cells to IgG2 and IgG4, respectively (Agresti and Vercelli, 2002; Tanaka et al., 2003). In the present study, there was an increase in the numbers of IgG4+ B-cells and plasma cells in comparison with IgG2+ cells in periodontitis lesions, but not healthy/gingivitis tissues, and numbers increased with increasing inflammation, suggesting higher levels of IL-4 with disease progression. Since tryptase+ mast cell numbers decreased in periodontitis tissues, it is possible that these cells do not constitute an IL-4-producing subset. The constant numbers of c-kit+ mast cells, regardless of clinical status or degree of inflammation, also indicate that there may be no increased migration of mast cells into the lesion.
In conclusion, tryptase+ mast cell numbers decreased with increasing inflammation in periodontal disease lesions. The numbers of c-kit+ mast cells, while lower than those of tryptase+ cells, remained constant. There was an increase in the numbers of IgG4+ cells compared with IgG2+ cells in periodontitis lesions, and IgG4+ cell numbers increased with increasing inflammation, indicating a predominance of Th2 responses in progressive periodontitis. The association of decreased tryptase+ mast cells with increased Th2 responses suggests that mast cells in periodontitis may not be the source of Th2 cytokines. However, since there were no differences in IgG2+ cell numbers, the c-kit+ population of mast cells may influence Th1 responses and therefore the IgG2+ cell population in periodontal disease.
| ACKNOWLEDGMENTS |
|---|
Received August 18, 2003; Last revision February 24, 2004; Accepted February 25, 2004
| REFERENCES |
|---|
|
|
|---|
Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, et al. (1991). Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173:869879.
Fox CC, Jewell SD, Whitacre CC (1994). Rat peritoneal mast cells present antigen to a PPD-specific T-cell line. Cell Immunol 158:253264.[ISI][Medline]
Frandji P, Tkaczyk C, Oskeritzian C, David B, Desaymard C, Mecheri S (1996). Exogenous and endogenous antigens are differentially presented by mast cells to CD4+ T lymphocytes. Eur J Immunol 26:25172528.[ISI][Medline]
Galli SJ, Tsai M, Wershil BK, Tam SY, Costa JJ (1995). Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int Arch Allergy Immunol 107:5153.[ISI][Medline]
Gemmell E, Seymour GJ (1995). Gamma delta T lymphocytes in human periodontal disease tissue. J Periodontol 66:780785.[ISI][Medline]
Gemmell E, Yamazaki K, Seymour GJ (2002). Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med 13:1734.
Gemmell E, Winning TA, Carter CL, Ford PJ, Bird PS, Ashman RB, et al. (2003). Differences in mouse strain influence leukocyte and immunoglobulin phenotype response to Porphyromonas gingivalis. Oral Microbiol Immunol 18:364370.[ISI][Medline]
Gurish MF, Boyce JA (2002). Mast cell growth, differentiation, and death. Clin Rev Allergy Immunol 22:107118.[ISI][Medline]
Irani AM, Schwartz LB (1989). Mast cell heterogeneity. Clin Exp Allergy 19:143155.[ISI][Medline]
Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB (1986). Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 83:44644468.
Malaviya R, Twesten NJ, Ross EA, Abraham SN, Pfeifer JD (1996). Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol 156:14901496.[Abstract]
Marietta EV, Chen Y, Weis JH (1996). Modulation of expression of the anti-inflammatory cytokines interleukin-13 and interleukin-10 by interleukin-3. Eur J Immunol 26:4956.[ISI][Medline]
Mécheri S, David B (1997). Unravelling the mast cell dilemma: culprit or victim of its generosity? Immunol Today 18:212215.[ISI][Medline]
Mekori YA, Metcalfe DD (1999). Mast cell-T cell interactions. J Allergy Clin Immunol 104:517523.[ISI][Medline]
Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE (1989). Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339:6467.[Medline]
Reinhardt RA, Bolton RW, McDonald TL, DuBois LM, Kaldahl WB (1988). In situ lymphocyte subpopulations from active versus stable periodontal sites. J Periodontol 59:656670.[ISI][Medline]
Seymour GJ, Powell RN, Aitken JF (1983). Experimental gingivitis in humans. A clinical and histologic investigation. J Periodontol 54:522528.[ISI][Medline]
Shanas U, Bhasin R, Sutherland AK, Silverman AJ, Silver R (1998). Brain mast cells lack the c-kit receptor: immunocytochemical evidence. J Neuroimmunol 90:207211.[ISI][Medline]
Smith TJ, Ducharme LA, Weis JH (1994). Preferential expression of interleukin-12 or interleukin-4 by murine bone marrow mast cells derived in mast cell growth factor or interleukin-3. Eur J Immunol 24:822826.[ISI][Medline]
Tanaka S, Barbour SE, Best AM, Schenkein HA, Tew JG (2003). Prostaglandin E2-mediated regulation of immunoglobulin G2 via interferon gamma. J Periodontol 74:771779.[ISI][Medline]
Wasserman SI (1994). Mast cells and airway inflammation in asthma. Am J Respir Crit Care Med 150:S39S41.
This article has been cited by other articles:
![]() |
T. Minami, T. Kuroishi, A. Ozawa, H. Shimauchi, Y. Endo, and S. Sugawara Histamine Amplifies Immune Response of Gingival Fibroblasts J. Dent. Res., November 1, 2007; 86(11): 1083 - 1088. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® |
| Journal of Dental Research ® | Critical Reviews (1990-2004) |